FDA panel backs Valeant psoriasis drug with risk program
 

FDA panel backs Valeant psoriasis drug with risk program
(Reuters) - Valeant Pharmaceuticals International Inc's experimental drug to treat the skin disorder psoriasis should be approved as long as certain measures are put in place to mitigate the risk of suicide, an advisory committee to the U.S. Food and Drug Administration concluded on Tuesday.http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...eE:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...eE:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/hF3Cmxncr3o